NVS

Recent Articles

11 Pharmaceuticals Stocks to Sell Now

This week, the ratings of 11 Pharmaceuticals stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

4 Stocks to Save You From the Next Market Crash

Is the next market brushfire right around the corner? Here are 4 stocks to add to your portfolio that can shield you from danger More 

10 Pharmaceuticals Stocks to Sell Now

The ratings of 10 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

Broker Darlings of the Dow: Pfizer Inc. (PFE)

A study of recommendations at the major brokerages shows Pfizer is the #7 broker pick, out of the 30 stocks in the Dow More 

Johnson & Johnson: My Favorite Dividend King (JNJ)

Johnson & Johnson is one of the strongest dividend payers the market's have to offer. Here's why I'm willing to pay a premium to own JNJ stock More 

Intellia Therapeutics IPO: The “Biggest Biotech Discovery of the Century”

Intellia Therapeutics' upcoming IPO could bring "the biggest biotech discovery of the century" to a down-and-out biotech sector. More 

Novartis AG (ADR) (NVS) Under Investigation for ‘Sham’ Events

Novartis is under investigation for alleged 80,000 sham events it held for doctors as part of a case concerning illegal kickbacks. More